1.

Box 1: Eligibility criteria for PrEP reimbursement in Belgium (issued by the National institute for Health and Disability Insurance as of June 1, 2017).

2.

Box 1: Eligibility criteria for PrEP reimbursement in Belgium (issued by the National institute for Health and Disability Insurance as of June 1, 2017).

3.

Box 1: Eligibility criteria for PrEP reimbursement in Belgium (issued by the National institute for Health and Disability Insurance as of June 1, 2017).

4.

Box 1: Eligibility criteria for PrEP reimbursement in Belgium (issued by the National institute for Health and Disability Insurance as of June 1, 2017).

5.

Box 1: Eligibility criteria for PrEP reimbursement in Belgium (issued by the National institute for Health and Disability Insurance as of June 1, 2017).

6.

Box 1: Eligibility criteria for PrEP reimbursement in Belgium (issued by the National institute for Health and Disability Insurance as of June 1, 2017).

7.

Box 1: Eligibility criteria for PrEP reimbursement in Belgium (issued by the National institute for Health and Disability Insurance as of June 1, 2017).

8.

Box 1: Eligibility criteria for PrEP reimbursement in Belgium (issued by the National institute for Health and Disability Insurance as of June 1, 2017).

9.

Box 1: Eligibility criteria for PrEP reimbursement in Belgium (issued by the National institute for Health and Disability Insurance as of June 1, 2017).

1.

Box 2: The MSM specific and high-risk group eligibility criteria adjusted to SSA migrants and operationalized by the TOGETHER data.

2.

Box 2: The MSM specific and high-risk group eligibility criteria adjusted to SSA migrants and operationalized by the TOGETHER data.

3.

Box 2: The MSM specific and high-risk group eligibility criteria adjusted to SSA migrants and operationalized by the TOGETHER data.

4.

Box 2: The MSM specific and high-risk group eligibility criteria adjusted to SSA migrants and operationalized by the TOGETHER data.

5.

Box 2: The MSM specific and high-risk group eligibility criteria adjusted to SSA migrants and operationalized by the TOGETHER data.

1.

Graph 3: Percentages of SSA migrants meeting the PrEP eligibility criteria*.

2.

Graph 3: Percentages of SSA migrants meeting the PrEP eligibility criteria*.

3.

Graph 3: Percentages of SSA migrants meeting the PrEP eligibility criteria*.

4.

Graph 3: Percentages of SSA migrants meeting the PrEP eligibility criteria*.

5.

Graph 3: Percentages of SSA migrants meeting the PrEP eligibility criteria*.

1.

Factors associated with eligibility to PrEP in bivariate and multivariable logistic analysis (weighted data).

2.

Factors associated with eligibility to PrEP in bivariate and multivariable logistic analysis (weighted data).

3.

Factors associated with eligibility to PrEP in bivariate and multivariable logistic analysis (weighted data).

4.

Factors associated with eligibility to PrEP in bivariate and multivariable logistic analysis (weighted data).

5.

Factors associated with eligibility to PrEP in bivariate and multivariable logistic analysis (weighted data).

1.

Adherence to the 2015 Dutch dietary guidelines and risk of non-communicable diseases and mortality in the Rotterdam study

2.

Adherence to the 2015 Dutch dietary guidelines and risk of non-communicable diseases and mortality in the Rotterdam study

3.

Adherence to the 2015 Dutch dietary guidelines and risk of non-communicable diseases and mortality in the Rotterdam study

4.

Adherence to the 2015 Dutch dietary guidelines and risk of non-communicable diseases and mortality in the Rotterdam study

1.

'It is not the fading candle that one expects': general practitioner's perspectives on life-preserving versus 'letting go' decision-making in end-of-life home care

2.

'It is not the fading candle that one expects': general practitioner's perspectives on life-preserving versus 'letting go' decision-making in end-of-life home care

3.

'It is not the fading candle that one expects': general practitioner's perspectives on life-preserving versus 'letting go' decision-making in end-of-life home care

4.

'It is not the fading candle that one expects': general practitioner's perspectives on life-preserving versus 'letting go' decision-making in end-of-life home care

1.

Surgical Treatment of Early-Stage Cervical Cancer:A Multi-Institution Experience in 2124 Cases in The Netherlands Over a 30-Year Period

2.

Surgical Treatment of Early-Stage Cervical Cancer:A Multi-Institution Experience in 2124 Cases in The Netherlands Over a 30-Year Period

3.

Surgical Treatment of Early-Stage Cervical Cancer:A Multi-Institution Experience in 2124 Cases in The Netherlands Over a 30-Year Period

4.

Surgical Treatment of Early-Stage Cervical Cancer:A Multi-Institution Experience in 2124 Cases in The Netherlands Over a 30-Year Period

1.

Data from : Niche separation of wetland birds revealed from airborne laser scanning

2.

Data from : Niche separation of wetland birds revealed from airborne laser scanning

3.

Data from : Niche separation of wetland birds revealed from airborne laser scanning

4.

Data from : Niche separation of wetland birds revealed from airborne laser scanning

1.

Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer

2.

Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer

3.

Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer

4.

Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer

1.

Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule

2.

Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule

3.

Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule

4.

Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule